FDA Approves New Oral Antibiotic Blujepa For UTI Treatment In Women And Teens
The FDA has approved Blujepa (gepotidacin), a first-in-class oral antibiotic for uncomplicated urinary tract infections (uUTIs) in women and children aged 12 and older. Clinical trials showed its ...
FDA approves first new antibiotic for UTIs in nearly 30 years
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
The American Journal of Managed Care9h
FDA Approves First New Class of Oral Antibiotics for Uncomplicated UTIs in Nearly 30 Years
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...